As of the close on September 2, 2025, PHAXIAM Therapeutics S.A.'s stock has declined approximately 94.48% over the past 52 weeks. The 50-day moving average sits at 0.37, while the 200-day moving average is 2.72.
| 52-Week Price Change | -94.48% |
| 50-Day Moving Average | 0.37 |
| 200-Day Moving Average | 2.72 |
PHAXIAM Therapeutics S.A.'s most recent stock split took place on June 14, 2024 with a 1000:1081 split ratio.
| Last Split Date | 6/14/2024 |
| Split Ratio | 1000:1081 |
Already premium?